Optimapharm Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
510
- Latest Deal Type
-
Debt Refin.
- Financing Rounds
-
6
- Investments
-
6
Optimapharm General Information
Description
Provider of clinical research services intended to explore various aspects of medical science. The company offers services including project and data management, regulatory and ethics, monitoring services, medical writing, safety and pharmacovigilance in the emerging markets of Eastern and South-Eastern Europe, enabling pharma and medical device companies to reach both small and large patient populations in several indications, whilst achieving competitive start-up timelines at competitive prices.
Contact Information
Website
www.optimapharm.euCorporate Office
- Almeria Business Tower
- Ulica grada Vukovara 284s
- Zagreb, 10000
- Croatia
Corporate Office
- Almeria Business Tower
- Ulica grada Vukovara 284s
- Zagreb, 10000
- Croatia
Optimapharm Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Optimapharm Comparisons
Industry
Financing
Details
Optimapharm Competitors (25)
One of Optimapharm’s 25 competitors is Theorem Clinical Research, a Formerly PE-Backed company based in King of Prussia, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Theorem Clinical Research | Formerly PE-Backed | King of Prussia, PA | ||||
| Allucent (Cary) | Private Equity-Backed | Cary, NC | ||||
| North American Science Associates | Private Equity-Backed | Toledo, OH | ||||
| Veristat | Private Equity-Backed | Southborough, MA | ||||
| Resolian | Private Equity-Backed | Malvern, PA |
Optimapharm Signals
Optimapharm Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Optimapharm Investments & Acquisitions (6)
Optimapharm’s most recent deal was a Buyout/LBO with Qualitis. The deal was made on 27-Jun-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Qualitis | 27-Jun-2022 | Buyout/LBO | Consulting Services (B2B) | ||
| Clinical Trials Group | 19-Apr-2022 | Buyout/LBO | BPO/Outsource Services | ||
| SSS International Clinical Research | 15-Dec-2021 | Buyout/LBO | Other Healthcare Services | ||
| Syntax For Science | 12-Nov-2020 | Buyout/LBO | Other Healthcare Services | ||
| Denothex | 30-Jan-2019 | Buyout/LBO | Other Pharmaceuticals and Biotechnology |
Optimapharm FAQs
-
When was Optimapharm founded?
Optimapharm was founded in 2006.
-
Where is Optimapharm headquartered?
Optimapharm is headquartered in Zagreb, Croatia.
-
What is the size of Optimapharm?
Optimapharm has 510 total employees.
-
What industry is Optimapharm in?
Optimapharm’s primary industry is BPO/Outsource Services.
-
Is Optimapharm a private or public company?
Optimapharm is a Private company.
-
What is Optimapharm’s current revenue?
The current revenue for Optimapharm is .
-
How much funding has Optimapharm raised over time?
Optimapharm has raised $11.6M.
-
Who are Optimapharm’s investors?
Accession Capital Partners has invested in Optimapharm.
-
Who are Optimapharm’s competitors?
Theorem Clinical Research, Allucent (Cary), North American Science Associates, Veristat, and Resolian are some of the 25 competitors of Optimapharm.
-
When was Optimapharm acquired?
Optimapharm was acquired on 09-Dec-2021.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process